Ozempic (semaglutide) 1 mg/— solution for injection in pre-filled pen, 1 pen Delivery of medications from Europe and beyond within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp. Payment upon delivery

Indications for Ozempic®

Ozempic® is indicated for use in adult patients with type 2 diabetes mellitus, along with diet and exercise, to improve glycemic control as:

monotherapy;

combination therapy with other oral hypoglycemic agents - metformin, metformin and a sulfonylurea derivative, metformin and/or a thiazolidinedione, in patients who have not achieved adequate glycemic control with previous therapy;

combination therapy with insulin in patients who have not achieved adequate glycemic control with Ozempic® and metformin.

Ozempic® is indicated to reduce the risk of major cardiovascular events* in patients with type 2 diabetes mellitus and high cardiovascular risk as an adjunct to standard treatment. cardiovascular diseases (based on the analysis of the time of occurrence of the first major cardiovascular event - see the section "Pharmacological action", subsection "Assessment of the effect on the cardiovascular system").